Xian, Shaanxi
Disclosures:
2266 - Investigation of the Dosimetric Advantages of a Novel X-Ray and ?-Ray Combined Modality in Prostate Cancer Treatment
Sunday, September 29, 20244:45 PM – 6:00 PM ET